KENDRA SALAZAR: Open Payments
NPI 1770796872 · SUGAR LAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$18,362 in 273 payments from 22 companies in 2025. Trend: 2023 $32,385 · 2024 $15,353 · 2025 $18,362
Speaker / faculty: $10,000Food & beverage: $4,705Consulting: $1,652Travel & lodging: $1,045Honoraria: $960
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 15 | $6,306 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 19 | $6,230 |
| Organon LLC | 23 | $1,281 |
| LEO Pharma Inc. | 36 | $862 |
| E.R. Squibb & Sons, L.L.C. | 19 | $738 |
| ABBVIE INC. | 30 | $482 |
| Arcutis Biotherapeutics, Inc. | 40 | $473 |
| Novartis Pharmaceuticals Corporation | 20 | $349 |
| Regeneron Healthcare Solutions, Inc. | 8 | $252 |
| Incyte Corporation | 10 | $241 |
Products named: Cabtreo, VTAMA, ADBRY, Zoryve, SKYRIZI, DUPIXENT, OPZELURA, COSENTYX.
Industry payments across TX — which companies pay providers there.
